Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 725.28

+3.0%

Nov 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Felix B who wrote (2295)	2/9/2018 1:40:13 PM
From: Miljenko Zuanic	Read Replies (1) of 3559

<Yes 3/10 is when they are releasing praulent outcome, I don't have a lot of expectations and I don't think anyone else does but that only means upside right?. Definitely not! re CVOT If they are under 20% benefit (and they failed 18% at interim), Praluent sale will further come under pressure from Repatha and Payers. Estimate will come down, ...and here we go again.....<300! Key is Eylea, can it hold +$4B in US sale, in 2019/2020. If you have crystal boll, please, let as know? I have one, but it is only for my personal use.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next